Valgen Medtech Patents

Patent portfolio assigned to Valgen Medtech (verified via public assignee records). Estimated patent count: 150. Hangzhou structural-heart (transcatheter mitral/tricuspid repair, DragonFly) company. Patents confirmed on Valgen's own profile page: 500+ applied worldwide, 150+ granted by end-2023 (estimate = granted). Direct competitors are the global TEER device makers Abbott and Edwards plus Chinese peer/partner Venus Medtech. Being a device maker, it has hospitals as end-users rather than named corporate customers; listed the confirmed Venus Medtech strategic partnership.